Not specified, 2024 · DOI: https://doi.org/10.21203/rs.3.rs-4196316/v1 · Published: April 4, 2024
Spinal cord injury (SCI) can lead to long-term disabilities due to a complex cascade of events including inflammation. This study investigates the role of CD11b, a protein involved in immune cell function, in this process. The researchers used mice that lacked the CD11b gene to see how its absence affected the inflammatory response and recovery after SCI. They examined various markers of inflammation and assessed the mice's motor and sensory functions. The study found that removing CD11b altered the inflammatory response, improved motor function, reduced hypersensitivity to stimuli, and limited tissue damage after SCI, suggesting CD11b plays a role in SCI pathophysiology.
CD11b represents a potential therapeutic target for novel strategies to treat SCI.
Ligand-specific blockade of CD11b could target regional inflammation without affecting host defense, a potential future therapeutic direction.
Delayed administration of CD11b antagonists may attenuate allodynia following SCI.